Phosphatidylinositol 3-kinase mediates neuroprotection by estrogen in cultured cortical neurons

Journal of Neuroscience Research

Volumn 60, Issue 3, 2000, Pages 321-327

  Honda, Kazuhiro ^a   Sawada, Hideyuki ^a   Kihara, Takeshi ^a   Urushitani, Makoto ^a   Nakamizo, Tomoki ^a   Akaike, Akinori ^a   Shimohama, Shun ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; Estrogen; Neuroprotection; Phosphatidylinositol 3 kinase

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; ANTIESTROGEN; ESTRADIOL; ESTROGEN; FULVESTRANT; GLUTAMIC ACID; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BRAIN CELL; CELL VIABILITY; COGNITIVE DEFECT; CONTROLLED STUDY; ESTROGEN THERAPY; FETUS; IMMUNOBLOTTING; MENOPAUSE; NERVE CELL CULTURE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BLOTTING, WESTERN; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; CHROMONES; ENZYME INHIBITORS; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGENS; EXCITATORY AMINO ACID ANTAGONISTS; FLAVONOIDS; GLUTAMIC ACID; MORPHOLINES; NEURONS; NEUROPROTECTIVE AGENTS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0034193219     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(20000501)60:3<321::AID-JNR6>3.0.CO;2-T     Document Type: Article

References (45)

1. Bayne K. 1996. Revised guide for the care and use of laboratory animals available. American Physiological Society. Physiologist 39:199-208.
2. Behl C, Widmann M, Trapp T, Holsboer F. 1995. 17-β estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem Biophys Res Commun 216:473-482.
3. Behl C, Skutella T, Lezoualc'h F, Post A, Widmann M, Newton CJ, Holsboer F. 1997. Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol Pharmacol 51:535-541.
4. Crowder RJ, Freeman RS. 1998. Phosphatidylinositol 3-kinase and Akt protein kinase are necessary and sufficient for the survival of nerve growth factor-dependent sympathetic neurons. J Neurosci 18:2933-2943.
5. Escobedo JA, Kaplan DR, Kavanaugh WM, Turck CW, Williams LT. 1991. A phosphatidylmositol-3 kinase binds to platelet-derived growth factor receptors through a specific receptor sequence containing phosphotyrosine. Mol Cell Biol 11:1125-1132.
6. Eves EM, Xiong W, Bellacosa A, Kennedy SG, Tsichlis PN, Rosner MR, Hay N. 1998. Akt, a target of phosphatidylinositol 3-kinase, inhibits apoptosis in a differentiating neuronal cell line. Mol Cell Biol 18:2143-2152.
7. Garcia-Segura LM, Cardona-Gomez P, Naftolin F, Chowen JA. 1998. Estradiol upregulates Bcl-2 expression in adult brain neurons. NeuroReport 9:593-597.
8. Gollapudi L, Oblinger MM. 1999. Estrogen and NGF synergistically protect terminally differentiated, ERα-transfected PC12 cells from apoptosis. J Neurosci Res 56:471-481.
9. Goodman Y, Bruce AJ, Cheng B, Mattson MP. 1996. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid β-peptide toxicity in hippocampal neurons. J Neurochem 66:1836-1844.
10. Green PS, Bishop J, Simpkins JW. 1997. 17 α-Estradiol exerts neuroprotective effects on SK-N-SH cells. J Neurosci 17:511-515.
11. Gridley KE, Green PS, Simpkins JW. 1997. Low concentrations of estradiol reduce β-amyloid (25-35)-induced toxicity, lipid peroxidation and glucose utilization in human SK-N-SH neuroblastoma cells. Brain Res 778:158-165.
12. Gridley KE, Green PS, Simpkins JW. 1998. A novel, synergistic interaction between 17 β-estradiol and glutathione in the protection of neurons against β-amyloid 25-35-induced toxicity in vitro. Mol Pharmacol 54: 874-880.
13. Henderson VW, Paganini-Hill A, Emanuel CK, Dunn ME, Buckwalter JG. 1994. Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects. Arch Neurol 51:896-900.
14. Kihara T, Shimohama S, Sawada H, Kimura J, Kume T, Kochiyama H, Maeda T, Akaike A. 1997. Nicotinic receptor stimulation protects neurons against β-amyloid toxicity. Ann Neurol 42:159-163.
15. Masliah E, Terry RD, Alford M, DeTeresa R, Hansen LA. 1991. Cortical and subcortical patterns of synaptophysin-like immunoreactivity in Alzheimer's disease. Am J Pathol 138:235-246.
16. Miranda RC, Sohrabji F, Toran-Allerand D. 1994. Interactions of estrogen with the neurotrophins and their receptors during neural development. Horm Behav 28:367-375.
17. Moss RL, Gu Q, Wong M. 1997. Estrogen: nontranscriptional signaling pathway. Recent Prog Horm Res 52:33-68.
18. Paganini-Hill A, Henderson VW. 1994. Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol 140:256-261.
19. Paganini-Hill A, Henderson VW. 1996. Estrogen replacement therapy and risk of Alzhemier's disease. Arch Intern Med 156:2213-2217.
20. Philpott KL, McCarthy MJ, Klippel A, Rubin LL. 1997. Activated phosphatidylinositol 3-kinase and Akt kinase promote survival of superior cervical neurons. J Cell Biol 139:809-815.
21. Pike CJ. 1999. Estrogen modulates neuronal Bcl-xL expression and β-amyloid-induced apoptosis: relevance to Alzheimer's disease. J Neurochem 72:1552-1563.
22. Pong K, Xu RY, Baron WF, Loius JC, Beck KD. 1998. Inhibition of phosphatidyhnositol 3-kinase activity blocks cellular differentiation mediated by glial cell line-derived nenrotrophic factor in dopaminergic neurons. J Neurochem 71:1912-1919.
23. Qiu YH, Zhao X, Hayes RL, Perez-Polo JR, Pike BR, Huang L, Clifton GL, Yang K. 1998. Activation of phosphatidylinositol 3-kinase by brain-derived neurotrophic factor gene transaction in septo-hippocampal cultures. J Neurosci Res 52:192-200.
24. Sawada H, Ibi M, Kihara T, Urushitain M, Akaike A, Shinohama S. 1998. Estradiol protects mesencephalic dopaminergic neurons from oxidative stress-induced neuronal death. J Neurosci Res 54:707-719.
25. Shimohama S, Ogawa N, Tamura Y, Akaike A, Tsukahara T, Iwata H, Kimura J. 1993. Protective effect of nerve growth factor against glutamate-induced neurotoxicity in cultured cortical neurons. Brain Res 632:296-302.
26. +-induced apoptosis of cerebellar grannie neurons via Akt kinase activation. FEBS Lett 437:221-224.
27. Simpkins JW, Singh M, Bishop J. 1994. The potential role for estrogen replacement therapy in the treatment of the cognitive decline and neurodegeneration associated with Alzheimer's disease. Neurobiol Aging 15(Suppl 2):S195-S197.
28. Singer CA, Rogers KL, Strickland TM, Dorsa DM. 1996. Estrogen protects primary cortical neurons from glutamate toxicity. Neurosci Lett 212:13-16.
29. Singer CA, Rogers KL, Dorsa DM. 1998. Modulation of Bcl-2 expression: a potential component of estrogen protection in NT2 neurons. Neuro-Report 9:2565-2568.
30. Singer CA, Figueroa-Masot XA, Batchelor RH, Dorsa DM. 1999. The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity m primary cortical neurons. J Neurosci 19:2455-2463.
31. Singh M, Setalo Jr G, Guan X, Warren M, Toran-Allerand CD. 1999. Estrogen-induced activation of mitogen-activated protein kinase in cerebral cortical explants: convergence of estrogen and neurotrophin signaling pathways. J Nenrosci 19:1179-1188.
32. Smith CL, Conneely OM, O'Malley BW. 1993. Modulation of the ligand-independent activation of the human estrogen receptor by hormone and antihormone. Proc Natl Acad Sci USA 90:6120-6124.
33. Songyang Z, Baltimore D, Cantley LC, Kaplan DR, Franke TF. 1997. Interleukin 3-dependent survival by the Akt protein kinase. Proc Natl Acad Sci USA 94:11345-11350.
34. Tamura Y, Sato Y, Akaike A, Shiomi H. 1992. Mechanisms of cholecystokinin-induced protection of cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity. Brain Res 592:317-25.
35. Tang MX, Jacobs D, Stern Y, Marder K, Schofield P, Gurland B, Andrews H, Mayeux R. 1996. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348:429-432.
36. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R. 1991. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30:572-580.
37. Toran-Allerand CD, Miranda RC, Bentham WD, Sohrabji F, Brown TJ, Hochberg RB, MacLusky NJ. 1992. Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Proc Natl Acad Sci USA 89:4668-4672.
38. Urushitani M, Shimohama S, Kihara T, Sawada H, Akaike A, Ibi M, Inoue R, Kitamura Y, Taniguchi T, Kimura J. 1998. Mechanism of selective motor neuronal death after exposure of spinal cord to glutamate: involvement of glutamate-induced nitric oxide in motor neuron toxicity and nonmotor neuron protection. Ann Neurol 44:796-807.
39. van Weering DH, Bos JL. 1998. Signal transduction by the receptor tyrosine kinase Ret. Recent Results Cancer Res 154:271-281.
40. Weaver Jr CE, Park-Chung M, Gibbs TT, Farb DH. 1997. 17β-Estradiol protects against NMDA-induced excitotoxicity by direct inhibition of NMDA receptors. Brain Res 761:338-341.
41. Weihl CC, Ghadge GD, Kennedy SG, Hay N, Miller RJ, Roos RP. 1999. Mutant presenilin-1 induces apoptosis and downregulates Akt/PKB. J Neurosci 19:5360-5369.
42. Wymann MP, Pirola L. 1998. Structure and function of phosphoinositide 3-kinases. Biochim Biophys Acta 1436:127-150.
43. Yamada M, Ohnishi H, Sano S, Nakatani A, Ikeuchi T, Hatanaka H. 1997. Insulin receptor substrate (IRS)-1 and IRS-2 are tyrosine-phosphorylated and associated with phosphatidylinositol 3-kinase in response to brain-derived nenrotrophic factor in cultured cerebral cortical neurons. J Biol Chem 272:30334-30339.
44. Zhang FX, Rubin R, Rooney TA. 1998. Ethanol induces apoptosis in cerebellar granule neurons by inhibiting insulin-like growth factor 1 signaling. J Neurochem 71:196-204.
45. Zhou H, Summers SA, Birnbaum MJ, Pittman RN. 1998. Inhibition of Akt kinase by cell-permeable ceramide and its implications for ceramide-induced apoptosis. J Biol Chem 273:16568-16575.